Appeal 2007-2521
Reexamination 90/007,130
1 (which is another name for octanoic acid) and ethylenediamine in admixture
2 with xylene. Yasuda, p. 9, l. 22-35.
3 PRINCIPLES OF LAW
4 Anticipation requires a showing that each limitation of a claim is
5 found in a single reference, either expressly or inherently. Perricone v.
6 Medicis Pharm. Corp., 432 F.3d 1368, 1375, 77 USPQ2d 1321, 1325 (Fed.
7 Cir. 2005). Even a single prior art species within the patent's claimed genus
8 reads on the generic claim and anticipates. Atlas Powder Co. v. IRECO Inc.,
9 190 F.3d 1342, 51 USPQ2d 1943, 1945-46 (Fed. Cir. 1999). A small genus
10 can be a disclosure of each species within the genus. In re Petering, 301
11 F.2d 676, 682, 133 USPQ 275, 280 (C.C.P.A. 1962); see also Bristol-Myers
12 Squibb Co. v. Ben Venue Labs., Inc., 246 F.3d 1368, 1380, 58 USPQ2d
13 1508, 1517 (Fed. Cir. 2001) (“[T]he disclosure of a small genus may
14 anticipate the species of that genus even if the species are not themselves
15 recited.”). Also, a reference may anticipate even when the relevant
16 properties of the thing disclosed were not appreciated at the time. Abbott
17 Laboratories v. Baxter Pharmaceutical Products Inc., 471 F.3d 1363, 1369,
18 80 USPQ2d 1860, 1863 (Fed. Cir. 2006); Titanium Metals Corp. v. Banner,
19 778 F.2d 775, 782, 227 USPQ 773, 778 (Fed. Cir. 1985).
20 References must be considered in their entirety and not limited to
21 specific examples contained in them. In re Fracalossi, 681 F.2d 792, 794
22 n.1, 215 USPQ 569, 571 n.1 (CCPA 1982); In re Lamberti, 545 F.2d 747,
23 750, 192 USPQ 278, 280 (CCPA 1976).
24 ANALYSIS
25 Claim 1
26 Yasuda describes rheological additives
- 5 -
Page: Previous 1 2 3 4 5 6 7 8 9 10 Next
Last modified: September 9, 2013